peptideNot FDA-approvedResearch chemicalNot an FDA- or EMA-approved drugNo PubMed-indexed peptide-specific study was identified for this compound; do not confuse with the unrelated rubidium-82 imaging product marketed as CardioGen-82
CardiogenBenefits, Dosage & Interactions
Cardiogen is a synthetic peptide bioregulator developed in Russia, belonging to the class of Khavinson peptides. These compounds are designed to interact with specific genetic sequences, influencing protein synthesis and cellular function. Research on Cardiogen focuses on heart and circulatory health and healthy aging.
Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Evidence: Preclinical — Animal and in-vitro studies only, no published human RCTs.
Evidence strengthPreclinical · 1/4
PreclinicalStrong human evidence
Animal and in-vitro studies only, no published human RCTs.
Plasma half-life
Not established
Default unit
mg
Mixing Cardiogen: bacteriostatic water and syringe units
The vial arrives as dry powder. How much water you add sets the strength, and the strength sets the mark you draw to on the syringe. The table assumes a 5 mg vial and a 250 mcg example draw on a U-100 insulin syringe, where 100 units is one millilitre. If your vial is a different size, scale it — the arithmetic is the same.
| Bacteriostatic water added | Resulting strength | 250 mcg draws to |
|---|---|---|
| 1 mL | 5 mg/mL | 5 units |
| 2 mL | 2.5 mg/mL | 10 units |
| 3 mL | 1.67 mg/mL | 15 units |
Units, not millilitres. Insulin syringes are marked in units, and mixing up mcg and mg on a peptide label is the single most common error people report. Check the label twice. Run your own vial through the calculator.
Storage and stability
- Before mixing
- Sealed and still as a dry powder, Cardiogen vials are normally kept in the fridge at 2–8 °C, out of light. Short spells at room temperature during shipping are the norm for lyophilized peptides and are not, on their own, a sign the vial is spoiled.
- After mixing
- Once bacteriostatic water goes in, the vial belongs in the fridge and is generally treated as good for about 28 days — that is how long the benzyl alcohol in bacteriostatic water is relied on to hold back bacterial growth. Plain sterile water has no preservative, so a vial mixed with it is a single-session vial. Never freeze a reconstituted vial.
- When to throw it out
- A properly mixed vial is clear. Cloudiness, floating strands, a color change or powder that will not go into solution after gentle swirling all mean the vial should be discarded rather than used. Shaking a peptide vial hard is the usual cause — swirl it, or run the water down the inside wall of the vial instead of onto the powder.
Handling and shelf-life figures describe general practice for lyophilized peptides. They are not a dose and not medical advice — your prescriber or the product label sets the amount.
What is Cardiogen studied for?
What is Cardiogen?
Cardiogen is a synthetic peptide bioregulator developed in Russia, belonging to the class of Khavinson peptides. These compounds are designed to interact with specific genetic sequences, influencing protein synthesis and cellular function. Cardiogen is specifically formulated to support the cardiovascular system. It is synthesized to mimic a portion of a natural peptide found in heart tissue, aiming to restore and maintain the functional integrity of cardiomyocytes, the cells of the heart muscle. Its short amino acid sequence is believed to allow it to act as a signaling molecule, modulating gene expression associated with cardiovascular health and potentially contributing to longevity by supporting the long-term health of the heart.
The concept behind peptide bioregulators like Cardiogen is rooted in the epigenetic theory of aging, which suggests that changes in gene expression, rather than just DNA mutations, play a significant role in the aging process. By interacting with DNA, these peptides are hypothesized to optimize gene expression, thereby improving cellular function and extending lifespan. Cardiogen is not a drug in the traditional sense, but rather a functional compound intended to support physiological processes. It is typically available as an oral supplement. Information regarding its use and efficacy largely stems from research conducted in Eastern Europe, particularly Russia. (Source: PubChem, DrugBank)
What does the research say about Cardiogen?
Tap a section to expand.
Cardiogen's proposed mechanism of action involves its ability to bind to specific regulatory regions of DNA within heart cells. This binding is thought to influence gene expression, promoting the synthesis of proteins crucial for the normal functioning and repair of cardiovascular tissues. Specifically, it is believed to enhance the activity of genes involved in antioxidant defense, cellular metabolism, and the structural integrity of cardiomyocytes. By modulating these pathways, Cardiogen may help to mitigate age- related changes in the heart, improve blood flow, and reduce oxidative stress. The peptide is hypothesized to work by restoring the balance of protein synthesis in aging or damaged cells, thereby optimizing their function and resilience. The short half-life of such peptides suggests that their effect is likely through brief, targeted signaling rather than sustained presence in the body. (Source: DrugBank)
Research on Cardiogen primarily focuses on its potential benefits for cardiovascular health and longevity, particularly in the context of aging.
* **Cardiovascular Support:** Studies, predominantly from Russian research, suggest that Cardiogen may help improve the functional state of the heart and blood vessels. This includes potential benefits for blood pressure regulation and overall cardiac performance. It is theorized to aid in maintaining the elasticity of blood vessels and supporting the contractility of the heart muscle.
* **Anti-Aging Effects:** By promoting optimal cellular function within the cardiovascular system, Cardiogen is posited to contribute to general anti-aging processes. The underlying theory is that if core physiological systems like the cardiovascular system are maintained, overall lifespan and healthspan can be enhanced.
* **Cellular Regeneration and Repair:** The peptide is believed to stimulate reparative processes in cardiomyocytes, which could be beneficial in conditions involving damage or stress to heart tissue. This regenerative potential is linked to its proposed ability to optimize protein synthesis and cellular metabolism.
It is important to note that much of the supporting evidence for these benefits comes from studies performed in former Soviet bloc countries, and further independent, large-scale clinical trials would be necessary to confirm these effects according to Western regulatory standards. (Source: PubChem)
The evidence supporting Cardiogen's benefits primarily comes from studies conducted in Russia and other Eastern European countries. These studies, often published in local journals, investigate the peptide's effects on various markers of cardiovascular health in both animal models and human subjects.
For instance, some research indicates improvement in various cardiovascular parameters in individuals receiving Cardiogen, including observations of improved heart function and adaptation to physical stress. These studies often employ methodologies that are different from those typically found in Western clinical research, and a critical evaluation of their findings often highlights smaller sample sizes and less rigorous control groups compared to trials required for FDA or EMA approval.
While promising, the results from these studies need to be corroborated by independent, double-blind, placebo-controlled trials designed to meet international standards. Currently, there is a lack of widespread, peer-reviewed evidence outside of the originating research groups to definitively establish Cardiogen's efficacy and safety in a broader population. Consumers should be aware of the geographical origin of the research when evaluating claims about this peptide. (Source: DrugBank)
Information regarding the side effects of Cardiogen is limited in readily accessible English-language scientific literature. Based on the general understanding of peptide bioregulators and available anecdotal reports from regions where it is more commonly used, Cardiogen is generally considered to have a low risk of adverse effects. Peptides, due to their specific receptor binding and short half-lives, tend to be more targeted in their action compared to broad-spectrum drugs.
Potential mild side effects could theoretically include:
* Transient discomfort at the site of administration (if injectable, though Cardiogen is typically oral).
* Mild gastrointestinal upset.
* Allergic reactions in susceptible individuals.
However, a comprehensive list of potential adverse reactions, their frequency, and severity, akin to what is provided for FDA-approved pharmaceuticals, is not readily available for Cardiogen. Users should discontinue use and consult a healthcare professional if any unexpected or severe reactions occur. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
As a peptide with specific effects on gene expression and cellular function, Cardiogen should be approached with caution, especially given the limited independent research outside of its country of origin. While generally considered safe based on available data, the long-term effects of modulating gene expression with synthetic peptides are not fully understood. Individuals with pre-existing medical conditions, particularly those related to the cardiovascular system, should exercise extreme caution. Pregnant or breastfeeding women should avoid Cardiogen due to a complete lack of safety data in these populations. Children should also not use this compound. It is advisable to consult a qualified healthcare professional before considering Cardiogen, especially if you are taking other medications or have any underlying health concerns. Self-diagnosis and self-treatment of serious conditions are not recommended. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Specific contraindications for Cardiogen are not extensively documented in widely accessible scientific literature. However, based on its intended use and general medical principles, the following situations would typically warrant avoidance or extreme caution:
* **Pregnancy and Breastfeeding:** A complete lack of safety data in pregnant or lactating individuals means Cardiogen should be avoided.
* **Pediatric Use:** Insufficient research exists regarding its effects on children, making its use contraindicated.
* **Known Allergies to Peptide Compounds:** Individuals with known hypersensitivities or allergic reactions to peptides or any components of the Cardiogen formulation should avoid its use.
* **Serious Underlying Medical Conditions:** While intended to support cardiovascular health, individuals with severe or uncontrolled heart conditions, such as acute myocardial infarction, unstable angina, or severe arrhythmias, should not use Cardiogen without explicit medical guidance due to the potential for unforeseen interactions or exacerbation of conditions.
Always discuss with a healthcare provider to ensure that Cardiogen is appropriate for your individual health profile. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Due to the limited research and lack of comprehensive clinical trials on Cardiogen in Western contexts, specific drug-drug or supplement-supplement interactions are not well-documented. However, as it is designed to impact cardiovascular function and gene expression, caution should be exercised when combining it with medications that also affect the heart or blood vessels.
Potential interactions could exist with:
* **Anticoagulants/Antiplatelet Drugs:** Though not directly observed, any compound affecting vascular function could theoretically alter coagulation.
* **Blood Pressure Medications:** Cardiogen's purported effects on blood pressure might potentiate or interfere with existing antihypertensive regimens.
* **Cardiovascular Drugs:** Any medication for heart conditions (e.g., for arrhythmias, heart failure) should be considered. Monitoring by a physician is crucial.
Always inform your healthcare provider about all supplements and medications you are currently taking before introducing Cardiogen to your regimen. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Cardiogen is typically administered orally, and its half-life is reported to be approximately 1 hour. Due to its short half-life, the effects of a single dose may be transient. The typical timing for Cardiogen administration can be either with or without food, as there are no specific dietary recommendations or restrictions mentioned for its absorption. It is often recommended to take small doses periodically throughout the day to potentially maintain more consistent levels, although specific dosage regimens vary based on the source and individual protocols. Following the manufacturer's or a healthcare professional's specific instructions for dosing frequency and timing is advised.
Put it into practice
Reading about Cardiogen is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with Cardiogen?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about Cardiogen
Cardiogen is primarily used to support cardiovascular health and is investigated for its potential anti-aging effects by optimizing heart cell function. (Source: PubChem)
No, Cardiogen is a synthetic peptide, meaning it is manufactured in a laboratory to mimic a naturally occurring peptide found in heart tissue.
While its half-life is about one hour, the biological effects of peptide bioregulators like Cardiogen, which influence gene expression, are typically not immediate and may require consistent use over time to manifest observable changes. (Source: DrugBank)
The legal status of Cardiogen varies by country. It is often available as a research chemical or dietary supplement in regions where it is not regulated as a pharmaceutical drug, particularly in Eastern European markets. (Source: DrugBank)
Documented severe side effects are not readily available in mainstream scientific literature. However, due to limited comprehensive studies, users should remain vigilant for any unusual or adverse reactions and consult a clinician. (Source: PubChem)
Cardiogen is a peptide, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Cardiogen with no sign-up.
Ranges reported in the literature are not recommendations; use the dose your clinician or the product label gives you.
Combining a peptide like Cardiogen with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Each peptide class carries its own profile against Cardiogen: a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Cardiogen varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Cardiogen depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Cardiogen the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Verify at
Publisher search links for Cardiogen. These are places to check the information — they are not citations, so they are not numbered.
- PubChem(publisher search, opens in a new tab)National Center for Biotechnology Information · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Cardiogen?
Plain-text summary, safe to quote verbatim:
Cardiogen is a synthetic peptide bioregulator developed in Russia, belonging to the class of Khavinson peptides. These compounds are designed to interact with specific genetic sequences, influencing protein synthesis and cellular function. Research on Cardiogen focuses on heart and circulatory health and healthy aging.
Source: DoseRoutine — https://doseroutine.com/library/cardiogen
Cardiogen cheat sheet
DoseRoutine cheat sheet · Peptide
Cardiogen
Cardiogen is a synthetic peptide bioregulator developed in Russia, belonging to the class of Khavinson peptides. These compounds are designed to interact with specific genetic sequences, influencing protein synthesis and cellular function.
Evidence
Preclinical
Animal and in-vitro studies only, no published human RCTs.
Not FDA-approvedResearch chemicalNot an FDA- or EMA-approved drugNo PubMed-indexed peptide-specific study was identified for this compound; do not confuse with the unrelated rubidium-82 imaging product marketed as CardioGen-82CardiovascularLongevity
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/cardiogen
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Cardiogen — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/cardiogen
What compounds are similar to Cardiogen?
Others in the peptide category or studied for the same goals.
Which goals is Cardiogen used for?
Other compounds studied for the same benefits as Cardiogen.
Heart & Circulation
See all →Continue exploring
See every compound DoseRoutine catalogs for these goals.